PRISM: Patient Experiences With PET Imaging in Prostate Cancer

Running, not enrolling

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to examine patient experiences, health-related quality of life, and decision-making associated with PET imaging for prostate cancer. In particular, Prostate Specific Membrane Antigen (PSMA) PET, a new and more sensitive form of imaging that can help identify metastatic cancer earlier and more reliably.

Key facts

Study ID
NCT06523777
Run by
Yale University
People needed
350
Starts
2024-07-25
Expected to finish
2028-07-25
Last updated by the study team
2026-05-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.